GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

The anatomical diagnoses were diabetes mellitus, as evidenced by the clinical findings and glycogen nephrosis, acute pyelonephritis, with necrotizing papillitis, a healing abscess over the left ...

Weight loss drugs like Ozempic, while transformative in combating obesity, have been linked to irreversible vision impairment ...

Of the nine patients, seven reported NAION-like symptoms; one had papillitis, an inflammation of the optic nerve head; and one individual developed paracentral acute middle maculopathy ...

It found that of nine patients, seven had nonarteritic anterior ischemic optic neuropathy, one had papillitis and another had patient is described with paracentral acute middle maculopathy.

One patient developed bilateral papillitis, which involves swollen optic nerves that can cause impaired vision, and another had paracentral acute middle maculopathy, which leads to a blind spot in ...

inhibitors that make those who take them feel fuller faster — has been linked to papillitis, and could be similar for NAION. As far as why, one possibility is that the drugs could have caused ...

Seven patients experienced NAION-like symptoms; one had papillitis, an inflammation of the optic nerve head; and one developed paracentral acute middle maculopathy, which can cause a blind spot in ...

Seven people experienced nonarteritic anterior ischemic optic neuropathy (NAION, or eye stroke), one person had papillitis (optic nerve inflammation), and one person had paracentral acute middle ...